Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

CELZ Creative Medical Technology Holdings Inc

3,82

0,00 (0,00%)

Pré-mercado

Última atualização: 05:00:00

Atrasado em 15 minutos

Form S-1 - General form for registration of securities under the Securities Act of 1933

nullnullnullnullnull

Creative Medical Technol... (NASDAQ:CELZ)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025

Click aqui para mais gráficos Creative Medical Technol....

Creative Medical Technol... (NASDAQ:CELZ)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025

Click aqui para mais gráficos Creative Medical Technol....

Notícias Creative Medical Technology Holdings Inc

Form PRE 14A - Other preliminary proxy statements
Sexta, 7 de Março de 2025 (4 dias atrás) • Edgar (US Regulatory)

Form 8-K - Current report
Sexta, 7 de Março de 2025 (4 dias atrás) • Edgar (US Regulatory)

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds
Quinta, 6 de Março de 2025 (5 dias atrás) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Quinta, 20 de Fevereiro de 2025 (3 semanas atrás) • Edgar (US Regulatory)

Creative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem® Program's Success and Growth Potential
Quinta, 20 de Fevereiro de 2025 (3 semanas atrás) • GlobeNewswire Inc.

Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™
Sexta, 14 de Fevereiro de 2025 (4 semanas atrás) • GlobeNewswire Inc.

Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program
Terça, 11 de Fevereiro de 2025 (4 semanas atrás) • GlobeNewswire Inc.

Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
Quarta, 5 de Fevereiro de 2025 (1 mês atrás) • GlobeNewswire Inc.

Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain
Quinta, 30 de Janeiro de 2025 (1 mês atrás) • GlobeNewswire Inc.

Form 8-K - Current report
Quinta, 26 de Dezembro de 2024 (2 meses atrás) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Quarta, 20 de Novembro de 2024 (4 meses atrás) • Edgar (US Regulatory)

Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment
Quarta, 13 de Novembro de 2024 (4 meses atrás) • GlobeNewswire Inc.

Mais Notícias de Creative Medical Technology Holdings Inc

Kisses from Italy (PK)

BNP Paribas Issuance

Societe Generale Effekten

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições